[MRI enterography for the assessment of inflammatory bowel disease]
Pichon Riviere A, Augustovski F, Garcia Marti S, Glujovsky D, Alcaraz A, Lopez A, Rey-Ares L, Bardach A, Ciapponi A, Urtasun M, Soto N
Record ID 32014000254
Spanish
Authors' objectives:
To assess the available evidence on the efficacy, safety and coverage related aspects regarding the use of MRI enterography for the assessment of inflammatory bowel disease.
Authors' recommendations:
The evidence selected from the SRs and the meta-analysis is of moderate methodological quality. Currently, CT is the most widely used radiological technique both for the diagnosis, when colonoscopy is contraindicated, and for inflammatory activity monitoring in patients with IBD. MRE´s diagnostic performance is similar to that of CT in CD; however, its cost is higher than CT. The CPGs and HTAs also cover the use of MRE mainly as an alternative in CD follow up. There is less evidence supporting the use of UC. MRE´s main advantage is not to expose the patient to ionizing radiation; a limit to its use would be the availability of resonators and/or qualified human resources.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
https://www.iecs.org.ar/home-ets/?cod_publicacion=1550&origen_publicacion=publicaciones
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Inflammatory Bowel Diseases
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.